Compare EchoStar Corporation Common Stock (ECHO) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
EchoStar Corporation Common Stock vs Halozyme Therapeutics Inc. Common Stock — how do they compare? EchoStar Corporation Common Stock trades at $97.99 (market cap $27.15B), while Halozyme Therapeutics Inc. Common Stock trades at $110.94 (market cap $12.58B). The key difference: EchoStar Corporation Common Stock is far larger — about 2.2× Halozyme Therapeutics Inc. Common Stock's market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, EchoStar Corporation Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold EchoStar Corporation Common Stock for 0 Days and Halozyme Therapeutics Inc. Common Stock for 0 Days on average.
| ECHO | HALO | |
|---|---|---|
Market Cap | $27.15B | $12.58B |
Volume | 4,944,235 | 2,179,278 |
Sector | Media | Health |
52-Week High | $141.80 | $115.22 |
52-Week Low | $66.93 | $61.63 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $44.21B | $14.49B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About EchoStar Corporation Common Stock
EchoStar provides satellite communications and connectivity services. Its businesses support broadband, enterprise, government, and consumer communications needs.
Read more on ECHO →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
